Beta-Glucans for Respiratory infections (yeast) and Beta-Glucans
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Evidence brief
Beta-Glucans for Respiratory infections (yeast)
Evidence grade C — Immune priming
Grade C1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Compound or practice
Beta-Glucans
Two different molecules under one name: oat beta-glucan reliably lowers LDL; yeast/mushroom beta-glucan modulates immunity.
Grade B3 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Beta-Glucans for Respiratory infections (yeast) | Beta-Glucans |
|---|---|---|
| Respiratory infections (yeast) | Evidence grade CSmall effectmixedImmune priming | Evidence grade CSmall effectmixedImmune priming |
Graded only in Beta-Glucans for Respiratory infections (yeast)
None — every outcome it grades is graded in both.
Graded only in Beta-Glucans
- LDL cholesterol (oat) Small effectEvidence grade A
- Post-meal glucose (oat) Small effectEvidence grade B
Conditions
Only in Beta-Glucans for Respiratory infections (yeast)
None.
Only in Beta-Glucans
- Dyslipidemia ImprovesEvidence grade A
What each entry says about the other
- Beta-Glucans for Respiratory infections (yeast)’s entry · Goes with: Read the full Beta-Glucans monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.